Apellis Pharmaceuticals to Host Conference Call on August 9, 2021 to Discuss Second Quarter 2021 Financial Results

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) plans to host a conference call and webcast on August 9, 2021, at 4:30 p.m. ET to discuss its second quarter 2021 financial results. Participants can join via phone or through the company’s website. A 90-day replay of the webcast will be accessible post-event. Apellis focuses on targeted C3 therapies and aims to develop transformative treatments for diseases driven by excessive complement activation. More information is available at www.apellis.com.

WALTHAM, Mass., July 29, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will host a conference call and webcast to discuss its second quarter 2021 financial results on Monday, August 9, 2021 at 4:30 p.m. ET.

The event will be available live by dialing (866) 774-0323 (domestic) or (602) 563-8683 (international) and entering the conference ID # 5762347 or via webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website at https://investors.apellis.com/events-and-presentations. A replay of the webcast will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com.

Investor Contact:
Argot Partners
apellis@argotpartners.com
+1 212.600.1902

 

FAQ

When is the Apellis Pharmaceuticals conference call for Q2 2021 results?

The conference call will be held on August 9, 2021, at 4:30 p.m. ET.

How can I access the Apellis Pharmaceuticals Q2 2021 results conference call?

You can access the call by dialing (866) 774-0323 for domestic calls or (602) 563-8683 for international calls, using conference ID # 5762347, or via the company's website.

What is the focus of Apellis Pharmaceuticals?

Apellis Pharmaceuticals specializes in targeted C3 therapies for various debilitating diseases driven by excessive complement activation.

Will the conference call for Q2 results be available for replay?

Yes, a replay of the conference call will be available for 90 days after the event.